Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11839709 | PMC |
| http://dx.doi.org/10.3389/fcell.2025.1540811 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Editorial: Machine learning in computer-aided drug design.
Front Mol Biosci
February 2025
Illumina, San Diego, CA, United States.
Blue and red LEDs modulate polyphenol production in Precoce and Tardiva cultivars of L.
Front Plant Sci
February 2025
Institute of Biosciences and Bioresources, National Research Council, Bari, Italy.
Introduction: Plant growth and metabolism can be optimized by manipulating light intensity and wavelength. Since the use of light-emitting diodes (LEDs) allows easy regulation of the light spectrum, LEDs technology is largely tested to produce high-quality food. Red leaf chicory is a horticultural plant of high commercial value, rich in vitamins, minerals and phytochemical compounds with bioprotective and antioxidant roles.
View Article and Find Full Text PDFNorth American study and meta-analysis evaluating performance of Bladder EpiCheck, a FDA cleared test, in non-muscle invasive bladder cancer recurrence.
Bladder Cancer
December 2024
Department of Urology, University of Texas Southwestern, Dallas, TX, USA.
Background: Bladder EpiCheck (BE) is a novel methylation-based PCR urine test for the detection of non-muscle invasive bladder cancer (NMIBC) recurrences.
Objective: We present the results of a North American study evaluating BE and meta-analysis of literature.
Methods: A prospective, blinded, multicenter study was conducted in North America.
Investigation into recent advanced strategies of reactive oxygen species-mediated therapy based on Prussian blue: Conceptualization and prospect.
Bioact Mater
June 2025
Biomaterials Research Center, Korea Institute of Science and Technology, Seoul, 02792, Republic of Korea.
Prussian blue (PB) has garnered considerable scholarly interest in the field of biomedical research owing to its notably high biocompatibility, formidable multi-enzyme mimetic capabilities, and established clinical safety profile. These properties in combination with its reactive oxygen species (ROS) scavenging activity have facilitated significant progress in disease diagnosis and therapy for various ROS-mediated pathologies, where overproduced ROS exacerbates disease symptoms. Additionally, the underlying ROS-associated mechanisms are disease-specific.
View Article and Find Full Text PDFSummary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer.
Bladder Cancer
February 2025
Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
The National Cancer Institute organized a virtual Clinical Trials Planning Meeting (CTPM) on 'Defining the next generation of clinical trials with combination therapies in non-muscle invasive bladder cancer (NMIBC)' led by the Bladder Cancer Task Force of the NCI Genitourinary Cancers Steering Committee. The purpose of this meeting was to accelerate advances in clinical trials for patients with high-risk NMIBC. The meeting delivered a multidisciplinary expert consensus on optimal strategies for next-generation clinical trial designs in NMIBC with prioritization of combination therapies.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!